BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17556179)

  • 1. Imaging of myocardial fatty acid metabolism with PET.
    Bergmann SR
    J Nucl Cardiol; 2007; 14(3 Suppl):S118-24. PubMed ID: 17556179
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution.
    Eckelman WC; Babich JW
    J Nucl Cardiol; 2007; 14(3 Suppl):S100-9. PubMed ID: 17556177
    [No Abstract]   [Full Text] [Related]  

  • 3. Future directions of myocardial fatty acid imaging.
    Pastore CJ; Babich JW; Udelson JE
    J Nucl Cardiol; 2007; 14(3 Suppl):S153-63. PubMed ID: 17556184
    [No Abstract]   [Full Text] [Related]  

  • 4. The Japanese experience with metabolic imaging in the clinical setting.
    Tamaki N; Morita K; Kawai Y
    J Nucl Cardiol; 2007; 14(3 Suppl):S145-52. PubMed ID: 17556183
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.
    Tu Z; Li S; Sharp TL; Herrero P; Dence CS; Gropler RJ; Mach RH
    Bioconjug Chem; 2010 Dec; 21(12):2313-9. PubMed ID: 21070001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
    Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
    J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution.
    Bockisch A; Freudenberg L; Rosenbaum S; Jentzen W
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1247-8. PubMed ID: 16909225
    [No Abstract]   [Full Text] [Related]  

  • 8. A new F-18 labeled PET tracer for fatty acid imaging.
    Demeure F; Cerqueira MD; Hesse M; Vancraeynest D; Roelants V
    J Nucl Cardiol; 2015 Apr; 22(2):391-4. PubMed ID: 25342213
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic Value of PET in Cardiac Sarcoidosis.
    Smedema JP; van Kroonenburgh MJ; Snoep G; Bekkers SC; Gorgels AP
    J Nucl Med; 2004 Nov; 45(11):1975. PubMed ID: 15534072
    [No Abstract]   [Full Text] [Related]  

  • 10. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
    Nakae I; Mitsunami K; Matsuo S; Horie M
    Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.
    Cerqueira M; Case J; Maddahi J
    J Nucl Cardiol; 2015 Aug; 22(4):730-9. PubMed ID: 26129941
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic imaging using PET.
    Kudo T
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S49-61. PubMed ID: 17486339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and regulation of CD36 for fatty acid imaging of the heart: implications in diabetes mellitus and chronic kidney disease.
    Aras O; Dilsizian V
    J Nucl Cardiol; 2007; 14(3 Suppl):S110-7. PubMed ID: 17556178
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological evaluation of 5-methyl-branched-chain omega-[18F]fluorofatty acid: a potential myocardial imaging tracer for positron emission tomography.
    Takahashi T; Nishimura S; Ido T; Ishiwata K; Iwata R
    Nucl Med Biol; 1996 Apr; 23(3):303-8. PubMed ID: 8782241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of l-5-(2-[(18)F]fluoroethoxy)tryptophan as a new PET tracer.
    Li R; Wu SC; Wang SC; Fu Z; Dang Y; Huo L
    Appl Radiat Isot; 2010 Feb; 68(2):303-8. PubMed ID: 19906535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
    DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
    J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-standard PET radionuclides: time to get ready for new clinical PET strategies.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):294-300. PubMed ID: 17187284
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of fatty acids in cardiac imaging.
    Tamaki N; Morita K; Kuge Y; Tsukamoto E
    J Nucl Med; 2000 Sep; 41(9):1525-34. PubMed ID: 10994734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic evidence of myocardial stunning in takotsubo cardiomyopathy: a positron emission tomography study.
    Obunai K; Misra D; Van Tosh A; Bergmann SR
    J Nucl Cardiol; 2005; 12(6):742-4. PubMed ID: 16344237
    [No Abstract]   [Full Text] [Related]  

  • 20. Production of iodine-124 and its applications in nuclear medicine.
    Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR
    Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.